0001209191-23-003987.txt : 20230119 0001209191-23-003987.hdr.sgml : 20230119 20230119160142 ACCESSION NUMBER: 0001209191-23-003987 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levisetti Matteo CENTRAL INDEX KEY: 0001962444 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 23537436 MAIL ADDRESS: STREET 1: C/O CUE BIOPHARMA, INC. STREET 2: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-01-17 0 0001645460 Cue Biopharma, Inc. CUE 0001962444 Levisetti Matteo C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 0 1 0 0 Chief Medical Officer Common Stock 9230 D Stock Option (right to buy) 13.14 2031-02-21 Common Stock 75000 D Stock Option (right to buy) 6.91 2032-02-08 Common Stock 43000 D Stock Option (right to buy) 5.01 2032-03-24 Common Stock 10000 D These stock options become exercisable in eight equal semi-annual installments beginning August 22, 2021. These stock options become exercisable in eight equal semi-annual installments beginning August 9, 2022. These stock options become exercisable in eight equal semi-annual installments beginning September 25, 2022. /s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact 2023-01-19